COVID-19 in patients with rheumatic disease in Hubei province, China: a multicentre retrospective observational study-Reference-Cited by-同舟云学术

COVID-19 in patients with rheumatic disease in Hubei province, China: a multicentre retrospective observational study

Published:2020-09 Issue:9 Volume:2 Page:e557-e564
ISSN:2665-9913
Container-title:The Lancet Rheumatology
language:en
Short-container-title:The Lancet Rheumatology

Author:

Zhong Jixin,Shen Guifen,Yang Huiqin,Huang Anbin,Chen Xiaoqi,Dong Li,Wu Bin,Zhang Anbin,Su Linchong,Hou Xiaoqiang,Song Shulin,Li Huiling,Zhou Wenyu,Zhou Tao,Huang Qin,Chu Aichun,Braunstein Zachary,Rao Xiaoquan,Ye Cong,Dong Lingli

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy,Rheumatology

Reference34 articles.

1. A pneumonia outbreak associated with a new coronavirus of probable bat origin;Zhou;Nature,2020

2. Clinical Characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China;Wang;JAMA,2020

3. DMARDS and infections in rheumatoid arthritis;Caporali;Autoimmun Rev,2008

4. Are my patients with rheumatic diseases at higher risk of COVID-19?;Figueroa-Parra;Ann Rheum Dis,2020

5. The immunology of COVID-19: is immune modulation an option for treatment?;Zhong;Lancet Rheumatol,2020

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Characteristics, Prognostic Factors, and Outcomes of COVID-19 in Autoimmune Rheumatic Disease Patients: A Retrospective Case–Control Study from Astana, Kazakhstan;Medicina;2024-08-23

2. Mendelian randomization and Bayesian model averaging of autoimmune diseases and Long COVID;Frontiers in Genetics;2024-06-20

3. Risk for COVID-19 Infection in Patients With Vitiligo;Cutis;2024-04-01

4. Clinical features of patients with rheumatic and musculoskeletal diseases during the coronavirus disease 2019 pandemic and the association of its relapse with infection: Across‐sectional study;International Journal of Rheumatic Diseases;2024-04

5. Incidence and disease burden of autoimmune inflammatory rheumatic diseases after non‐pharmaceutical interventions in the COVID‐19 era: A nationwide observational study in Korea;International Journal of Rheumatic Diseases;2024-04